Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravit ...